This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pilot Study of Vedic Medicine for Type 2 Diabetes

This study has been completed.
Information provided by:
National Center for Complementary and Integrative Health (NCCIH) Identifier:
First received: July 30, 2003
Last updated: April 14, 2015
Last verified: April 2015
The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Condition Intervention Phase
Diabetes Mellitus, Type 2 Drug: Vedic Medicine Behavioral: Vedic Medicine Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Further study details as provided by National Center for Complementary and Integrative Health (NCCIH):

Primary Outcome Measures:
  • HbA1C [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • Fasting Glucose [ Time Frame: 3 and 6 months ]
  • Lipids [ Time Frame: 3 and 6 months ]

Estimated Enrollment: 60
Study Start Date: July 2003
Estimated Study Completion Date: January 2004
Detailed Description:
Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.

Ages Eligible for Study:   25 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion criteria:

  • Kaiser Permanente members
  • Newly diagnosed type 2 Diabetes
  • Baseline glycosylated hemoglobin level of 6.0-7.9.

Exclusion criteria:

  • Pregnancy or nursing mother
  • Currently taking warfarin
  • Diagnosis of psychotic disorder or recent hospitalization for depression
  • Unable to comply with or attend treatment sessions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00065650

United States, Oregon
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227
Sponsors and Collaborators
National Center for Complementary and Integrative Health (NCCIH)
  More Information

Additional Information:
Elder C. Application of the cooperative health care clinic model for the delivery of complementary/ alternative care. The Permanente Journal. Winter 2003; 7(1):55-60.
Elder C. Complementary and Alternative Medicine Symposium: Integrating CAM into clinical practice: The KP northwest story. The Permanente Journal, Fall 2002, 6(4):57-59 Identifier: NCT00065650     History of Changes
Other Study ID Numbers: R21AT001324-01 ( U.S. NIH Grant/Contract )
Study First Received: July 30, 2003
Last Updated: April 14, 2015

Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
Diabetes Mellitus Type 2
Vedic medicine
Transcendental Meditation

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases processed this record on August 23, 2017